MULTIPLE MYELOMA (MM) - Celgene
Area of Research Phase 1 Phase 2 Phase 3 Post-Approval Research C C F P- esear C- C- T T appr LYMPHOMA REVLIMID® (lenalidomide) Mantle cell lymphoma: Relapsed/refractory . . . . . . . . . .
Download MULTIPLE MYELOMA (MM) - Celgene
Information
Domain:
Source:
Link to this page:
Documents from same domain
HIGHLIGHTS OF PRESCRIBING INFORMATION ... - …
media.celgene.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OTEZLA safely and effectively. See full prescribing information for
Reference ID: 3976113 - Celgene
media.celgene.comFor patients whose baseline counts are WBC <3.0 x109/L, ANC<1.5 x109/L, or platelets <75.0 x109/L, base dose adjustments on nadir counts and bone marrow biopsy cellularity
MEDICATION GUIDE - media.celgene.com
media.celgene.comCall your healthcare provider or get medical help right away if you get any of the following during treatment with POMALYST: Signs or symptoms of a blood clot in the lung, arm, or leg may include: shortness of breath, chest pain, or
HIGHLIGHTS OF PRESCRIBING INFORMATION ... - …
media.celgene.com4 Table 1: Dose Adjustments for Hematologic Toxicities for MM Platelet counts Thrombocytopenia in MM When Platelets Recommended Course .
MEDICATION GUIDE REVLIMID - Celgene
media.celgene.com42 MEDICATION GUIDE REVLIMID® (rev-li-mid) (lenalidomide) capsules What is the most important information I should know about REVLIMID? Before you begin taking REVLIMID, you must read and agree to all of the instructions in the REVLIMID
HIGHLIGHTS OF PRESCRIBING INFORMATION ...
media.celgene.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use POMALYSTsafely and effectively. See full …
HIGHLIGHTS OF PRESCRIBING INFORMATION ...
media.celgene.com1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ABRAXANE safely and effectively. See full prescribing
Related documents
Understanding your MULTIPLE MYELOMA LAB TESTS
www.velcade.comThis booklet explains common tests for patients with multiple myeloma. Your doctor uses them to help diagnose and assess your multiple myeloma,
Diagnosis and Follow-up of Multiple Myeloma and …
camlt.orgAnne L Sherwood, PhD Director of Scientific Affairs The Binding Site, Inc. Diagnosis and Follow-up of Multiple Myeloma and Related Disorders: The role of the laboratory
Subcutaneous Bortezomib (Velcade ), …
www.londoncanceralliance.nhs.ukSubcutaneous Bortezomib (Velcade®), Cyclophosphamide & Dexamethasone (VCD) for Multiple Myeloma Page 1 of 4
Multiple myeloma – lenalidomide Initial PBS …
www.perthhaematology.com.au4203.1209 1 of 4 Multiple myeloma – lenalidomide Initial PBS authority application and supporting information Purpose of this form You must lodge this form for a patient starting initial Pharmaceutical
HIGHLIGHTS OF PRESCRIBING INFORMATION ...
media.celgene.com3 full prescribing information warning: embryo-fetal toxicity, hematologic toxicity, and venous and arterial thromboembolism embryo-fetal toxicity
IMWG Criteria for the Diagnosis of Myeloma and …
myeloma.gr.jp1 IMWG Criteria for the Diagnosis of Myeloma and Guidelines for the Diagnostic Work-Up of Myeloma Criteria for a diagnosis of myeloma followed by the examinations, tests, and imaging studies
IMWG criteria - myeloma.gr.jp
myeloma.gr.jpInternational Myeloma Working Group (IMWG) Uniform Response Criteria for Multiple Myeloma 1 The International Myeloma Working Group established the below criteria in …